Battle for cancer drug lost
A retired fireman has suffered a setback in his battle to win funding for a cancer drug.Liver cancer patient Barry Humphrey has lost an appeal for a £5,000 trial for a drug aimed at buying him more time.
A retired fireman has suffered a setback in his battle to win funding for a cancer drug.
Liver cancer patient Barry Humphrey has lost an appeal for a £5,000 trial for a drug aimed at buying him more time.
His upset wife Hazel says health bosses have “sentenced him to an early death” .
Mr Humphrey, from North Walsham, said “my life is not worth £5,000” but is vowing to keep fighting.
You may also want to watch:
Back in May, the News told how, after 25 years' service saving lives as a fireman in London, he had developed a rare cancer, triggered by hepatitis caught from a casualty during a rescue.
But officials at NHS Norfolk have decided not to fund treatment recommended by his consultant, saying Mr Humphrey's case fails to meet national cost-effectiveness guidelines.
- 1 Joy as town's beer and gin festival set to return
- 2 Cafe reveals exciting revamp as town gets ready to reopen
- 3 Canal restoration resumes as lockdown winds up
- 4 Shock as public toilets torched FOUR times
- 5 Wanted Norwich man arrested in north Norfolk village
- 6 WATCH: Demolition of landmark seaside hotel
- 7 From Bradley Walsh to a charity bed push - hospital's history told in new wall feature
- 8 Safety review promised as cyclist killed in crash is named
- 9 'It was divine' - Why this seafood platter is receiving rave reviews online
- 10 'Why north Norfolk will bounce back'
NHS Norfolk medical director Bryan Heap said treatment funding decisions were taken on clinical rather than social circumstances, so Mr Humphrey's past as an exemplary citizen unfortunately could not be taken into consideration.
The cost of Sorafenib, along with administration, extra scans and follow-up was £150,000 a year, and trials indicated an increase in life expectancy of 12 weeks.